Overactive Bladder - Results from #360

An analysis of factors that influence patient preference of third-line therapy for overactive bladder. September 25, 2022

Efficacy and safety of transurethral resection of the prostate, holmium laser enucleation of the prostate, and photoselective vaporization of the prostate in management of overactive bladder symptoms complicating benign prostatic hyperplasia in patients w September 25, 2022

Peroneal electrical transcutaneous neuromodulation in the home treatment of the refractory overactive bladder. September 25, 2022

Vibegron for the treatment of overactive bladder: a comprehensive update. September 25, 2022

Agreement between the visual analogue scale (VAS) and the dysfunctional voiding scoring system (DVSS) in the post-treatment evaluation of electrical nerve stimulation in children and adolescents with overactive bladder. September 25, 2022

Mirabegron in the Management of Overactive Bladder Syndrome. September 25, 2022

Acupuncture for treating overactive bladder in adults. September 25, 2022

Medical Treatment of Overactive Bladder. September 18, 2022

Effects of Pelvic Floor Muscle Training on Sexual Dysfunction, Sexual Satisfaction of Partners, Urinary Symptoms, and Pelvic Floor Muscle Strength in Women With Overactive Bladder: A Randomized Controlled Study. September 18, 2022

Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population. September 18, 2022

Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings from a Randomized Trial. September 18, 2022

Physical Agent-Based Treatments for Overactive Bladder: A Review. September 11, 2022

Efficacy of Yun-type pelvic floor optimal training therapy and PFMT on middle aged women with mild to moderate overactive bladder: a randomized controlled trial. September 11, 2022

SUFU white paper on overactive bladder anticholinergic medications and dementia risk. September 11, 2022

Exposure to DEHP is potential to increase the risk of overactive bladder, evidence from NHANES 2003-2008. September 4, 2022

Does treatment of lichen sclerosus improve overactive bladder symptoms? September 4, 2022

Study of female pelvic floor muscle in overactive bladder based on MRI 3D reconstruction. September 4, 2022

The Differential Risk of Mortality Among Users of Overactive Bladder Anticholinergic Medications and β3 Agonists. August 28, 2022

Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials. August 28, 2022

Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States. August 28, 2022

Page 19 of 122